Inventor · disambiguated record
Hao Wu
Also filed as: WU HAO · WU HAO-HSIANG
41 granted patents·41 pending applications·162 citations·filing 2005–2025
96Inventor score
Files withMERCK SHARP & DOHME13BETTA PHARMACEUTICALS CO LTD7SHANGHAI CUREGENE PHARMACEUTICAL CO LTD5GENENTECH INC4WUXI FORTUNE PHARMACEUTICAL CO LTD4
Top patents by PatentIndex Score
82 records- 0196US8871759B2Inhibitors of hepatitis C virus replicationCOBURN CRAIG A·Filed 2010·Granted Oct 28, 2014·60 cites·20 claims
- 0291US9962388B2Pyrrolopyrimidine compounds used as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 8, 2018·14 cites·10 claims
- 0391US9090661B2Inhibitors of hepatitis C virus replicationMERCK SHARP & DOHME·Filed 2014·Granted Jul 28, 2015·18 cites·16 claims
- 0490US9938292B2Quinoline derivatives as SMO inhibitorsGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·19 cites·20 claims
- 0589US10597413B2Silicone-compatible compoundsHenkel IP & Holding GmbH·Filed 2018·Granted Mar 24, 2020·6 cites·28 claims
- 0688US10745389B2HDAC6 selective inhibitors, preparation method therefor, and application thereofCSTONE PHARMACEUTICALS (SUZHOU) CO LTD·Filed 2018·Granted Aug 18, 2020·6 cites·17 claims
- 0788US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 0886US9718828B2BTK InhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·7 cites·15 claims
- 0983US11434476B2Methods of editing DNA methylationWHITEHEAD INST BIOMEDICAL RES·Filed 2017·Granted Sep 6, 2022·6 cites·16 claims
- 1083US11059815B2Synthesis of small molecule histone deacetylase 6 degraders, compounds formed thereby, and pharmaceutical compositions containing themWISCONSIN ALUMNI RES FOUND·Filed 2020·Granted Jul 13, 2021·2 cites·14 claims
- 1182US11045458B2Synthesis of small molecule histone deacetylase 6 degraders, compounds formed thereby, and pharmaceutical compositions containing themWISCONSIN ALUMNI RES FOUND·Filed 2019·Granted Jun 29, 2021·2 cites·28 claims
- 1280US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 1379US2025011744A1Methods of editing dna methylationWHITEHEAD INST BIOMEDICAL RES·Filed 2024·Application pending·0 cites
- 1478US10555949B2Pyrrolopyrimidine compounds used as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Feb 11, 2020·2 cites·14 claims
- 1574US12060588B2Methods of editing DNA methylationWHITEHEAD INST BIOMEDICAL RES·Filed 2022·Granted Aug 13, 2024·0 cites·14 claims
- 1672US9481682B2Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 1, 2016·2 cites·23 claims
- 1771US2025129125A1Macrocyclic compounds and methods of use thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1867US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
- 1966US10087188B2Benzamide imidazopyrazine Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·1 cites·2 claims
- 2066US2025059544A1Antisense oligonucleotides (asos) that suppress sars-cov-2 replicationCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 2166US2024299345A1Ginkgolide b and its derivatives for inhibiting and/or reversing agingUNIV CHINA MEDICAL·Filed 2024·Application pending·0 cites
- 2265US9446130B2BTK inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Sep 20, 2016·1 cites·18 claims
- 2364US10174056B2Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 8, 2019·1 cites·20 claims
- 2464US2025049894A1Treatment of nudt2 mutationUNIV GENEVE·Filed 2022·Application pending·0 cites
- 2563US2024167039A1Method for treating lung injuryNATIONAL YANG MING CHIAO TUNG UNIV·Filed 2022·Application pending·0 cites
- 2662US9505739B2Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 29, 2016·0 cites·11 claims
- 2762US2025195669A1Folate-antibody conjugates as lysosome targeting degradersWISCONSIN ALUMNI RES FOUND·Filed 2023·Application pending·0 cites
- 2861US11834413B2Antiplatelet drugs and uses thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2023·Granted Dec 5, 2023·0 cites·9 claims
- 2961US2023115023A1Use of exosomes derived from mesenchymal stem cells fortreating non-alcoholic steatohepatitisUNIV CHINA MEDICAL·Filed 2022·Application pending·0 cites
- 3060US12187816B2Macrocyclic compounds and methods of use thereofGENENTECH INC·Filed 2021·Granted Jan 7, 2025·0 cites·16 claims
- 3160US11926633B2Synthesis methods for upadacitinib and intermediate thereofSUZHOU PENGXU PHARMATECH CO LTD·Filed 2019·Granted Mar 12, 2024·0 cites·2 claims
- 3260US2023076197A1Application of hypericum japonicum thumb extract in the preparation of a drgu against the blue-ear diseaseUNIV SUN YAT SEN·Filed 2022·Application pending·0 cites
- 3360US2025333382A1Antiplatelet drugs and uses thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 3460US2025361241A1Hpk1 inhibitor and medical use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 3560US2023038096A1Exosome enrichment by ultrafiltrationNATIONAL YANG MING CHIAO TUNG UNIV·Filed 2022·Application pending·0 cites
- 3659US2025152571A1Pharmaceutical composition of antiplatelet drug, and use thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 3758US11053243B2Inhibitors of hepatitis C virus replicationMERCK SHARP & DOHME·Filed 2020·Granted Jul 6, 2021·0 cites·12 claims
- 3858US2024026461A1Bcl10 mutations as biomarkers for targeted therapy in b cell lymphomasMELNICK ARI·Filed 2023·Application pending·0 cites
- 3958US2008274975A1Methods and Compositions for Inhibiting Abad/Abeta Protein InteractionUNIV COLUMBIA·Filed 2005·Application pending·0 cites
- 4058US2023391766A11-(2-(4-cyclopropyl-1h-1,2,3-triazol-1-yl)acetyl)-4-hydroxy-n-(benzyl)pyrrolidin e-2-carboxamide derivatives as vhl inhibitors for the treatment of anemia and cancerGENENTECH INC·Filed 2023·Application pending·0 cites
- 4158US2025312326A1Pharmaceutical composition of antiplatelet drug, and use thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 4258US2023271944A11-(2-(4-cyclopropyl-1h-1,2,3-triazol-1-yl)acetyl)-4-hydroxypyrrolidine-2-carboxa|mide derivatives as vhl inhibitors for the treatment of anemiaGENENTECH INC·Filed 2023·Application pending·0 cites
- 4357US2019127365A1Inhibitors of hepatitis c virus replicationMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 4456US12410132B2Antiplatelet drugs and uses thereofSHANGHAI CUREGENE PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 9, 2025·0 cites·14 claims
- 4555US2023321100A1Cd73 inhibitor and application thereof in medicineBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 4655US2017008906A1Inhibitors of hepatitis c virus replicationMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 4755US2022356182A1Inhibitors of hepatitis c virus replicationMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 4853US2021267996A1Compounds for inhibition of inflammationCHILDRENS MEDICAL CENTER·Filed 2019·Application pending·0 cites
- 4952US11427581B2JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Aug 30, 2022·0 cites·12 claims
- 5052US2023339882A1Shp2 inhibitor and composition and application thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hao Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →